213 related articles for article (PubMed ID: 2853065)
1. Antinociceptive effects of mu- and kappa-agonists in inflammation are enhanced by a peripheral opioid receptor-specific mechanism.
Stein C; Millan MJ; Yassouridis A; Herz A
Eur J Pharmacol; 1988 Oct; 155(3):255-64. PubMed ID: 2853065
[TBL] [Abstract][Full Text] [Related]
2. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors.
Stein C; Millan MJ; Shippenberg TS; Peter K; Herz A
J Pharmacol Exp Ther; 1989 Mar; 248(3):1269-75. PubMed ID: 2539460
[TBL] [Abstract][Full Text] [Related]
3. Opioid systems in the response to inflammatory pain: sustained blockade suggests role of kappa- but not mu-opioid receptors in the modulation of nociception, behaviour and pathology.
Millan MJ; Colpaert FC
Neuroscience; 1991; 42(2):541-53. PubMed ID: 1654538
[TBL] [Abstract][Full Text] [Related]
4. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
[TBL] [Abstract][Full Text] [Related]
5. The effects of sham and full spinalization on the systemic potency of mu- and kappa-opioids on spinal nociceptive reflexes in rats.
Herrero JF; Headley PM
Br J Pharmacol; 1991 Sep; 104(1):166-70. PubMed ID: 1664760
[TBL] [Abstract][Full Text] [Related]
6. Spinal antinociceptive actions and naloxone reversibility of intravenous mu- and kappa-opioids in spinalized rats: potency mismatch with values reported for spinal administration.
Parsons CG; West DC; Headley PM
Br J Pharmacol; 1989 Oct; 98(2):533-43. PubMed ID: 2555012
[TBL] [Abstract][Full Text] [Related]
7. The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration.
Wilson JL; Nayanar V; Walker JS
Br J Pharmacol; 1996 Aug; 118(7):1754-60. PubMed ID: 8842441
[TBL] [Abstract][Full Text] [Related]
8. Mu and kappa opioid modulation of olfactory bulb evoked potentials.
Pérez H; Hernández A; Inostroza H
Int J Neurosci; 1989 Dec; 49(3-4):329-32. PubMed ID: 2561634
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulatory activity of mu- and kappa-selective opioid agonists.
Taub DD; Eisenstein TK; Geller EB; Adler MW; Rogers TJ
Proc Natl Acad Sci U S A; 1991 Jan; 88(2):360-4. PubMed ID: 1846441
[TBL] [Abstract][Full Text] [Related]
10. Antagonist-induced opioid receptor up-regulation. I. Characterization of supersensitivity to selective mu and kappa agonists.
Millan MJ; Morris BJ; Herz A
J Pharmacol Exp Ther; 1988 Nov; 247(2):721-8. PubMed ID: 2846827
[TBL] [Abstract][Full Text] [Related]
11. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
Millan MJ; Członkowski A; Lipkowski A; Herz A
J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
[TBL] [Abstract][Full Text] [Related]
12. Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia.
Zhou L; Zhang Q; Stein C; Schäfer M
J Pharmacol Exp Ther; 1998 Aug; 286(2):1000-6. PubMed ID: 9694961
[TBL] [Abstract][Full Text] [Related]
13. Evidence that mu-opioid receptors mediate midbrain "stimulation-produced analgesia" in the freely moving rat.
Millan MJ; Członkowski A; Herz A
Neuroscience; 1987 Sep; 22(3):885-96. PubMed ID: 2825072
[TBL] [Abstract][Full Text] [Related]
14. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
Fox DA; Burks TF
J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
[TBL] [Abstract][Full Text] [Related]
15. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. I. Effects of opioid kappa receptor agonists bremazocine and U-50,488 on secretion of PRL and GH: comparison with morphine.
Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
Neuroendocrinology; 1986; 42(1):75-81. PubMed ID: 3001565
[TBL] [Abstract][Full Text] [Related]
16. Effects of intravenous mu and kappa opioid receptor agonists on sensory responses of convergent neurones in the dorsal horn of spinalized rats.
Dong XW; Parsons CG; Headley PM
Br J Pharmacol; 1991 May; 103(1):1230-6. PubMed ID: 1652344
[TBL] [Abstract][Full Text] [Related]
17. Involvement of mu-opioid receptors in the antitussive effects of pentazocine.
Kamei J; Katsuma K; Kasuya Y
Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):203-8. PubMed ID: 1314961
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade.
Pugsley MK; Penz WP; Walker MJ; Wong TM
Br J Pharmacol; 1992 Mar; 105(3):521-6. PubMed ID: 1320979
[TBL] [Abstract][Full Text] [Related]
19. Similar actions of kappa and mu agonists on spinal nociceptive reflexes in rats and their reversibility by naloxone.
Parsons CG; West DC; Headley PM
NIDA Res Monogr; 1986; 75():461-4. PubMed ID: 2828992
[TBL] [Abstract][Full Text] [Related]
20. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]